Intrinsic Value of S&P & Nasdaq Contact Us

Eliem Therapeutics, Inc. ELYM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
37/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Eliem Therapeutics, Inc. (ELYM) has 16 known insider and institutional holders on record. The largest holder is RA CAPITAL MANAGEMENT, L.P. with 1,807,000 shares. Other notable holders include Azelby Robert and Brennan Aoife.

ELYM Insider Ownership

Top Holder
RA CAPITAL MANAGEMENT, L.P.
1,807,000 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Ra Capital Management, L.p. 10 Percent Owner 1,807,000 2024-07-01
100%
2 Azelby Robert President & CEO 500,000 2022-11-02
28%
3 Brennan Aoife President and CEO 275,000 2024-06-27
15%
4 Lavelle Erin COO & CFO 170,000 2022-11-02
9%
5 Thomas Stephen Basil Director 100,375 2024-06-27
6%
6 Morisset Valerie EVP, R&d and CSO 100,322 2024-07-23
6%
7 Bucher James B EVP and General Counsel 95,000 2022-11-02
5%
8 Kaplan Brett Chief Operating Officer 77,500 2024-08-26
4%
9 Patterson Leone D Director 10,000 2022-06-01
1%
10 Shah Rajeev M. Director 10,000 2022-06-01
1%
11 Rosenberg Adam Joseph Director 10,000 2024-06-28
1%
12 Levin Andrew David Executive Chairman 10,000 2024-06-28
1%
13 Tate Simon Director 10,000 2024-06-28
1%
14 Dunn Judith Director 10,000 2024-06-28
1%
15 Ratcliffe Liam Director 10,000 2024-06-28
1%
16 Pimblett Emily Chief Accounting Officer 8,755 2024-09-20
0%

No ownership data available for ELYM.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message